We report here the hormonal, metabolic and gonadal responses to the glucagon-like peptide-1 (GLP1)-based multi-agonists, GLP1/Estrogen (GLP1/E), GLP1/gastric inhibitory peptide (GLP1/GIP) and GLP1/GIP/Glucagon, in two mouse PCOS models, with variable penetrance of metabolic and reproductive traits, and their comparison with metformin
Elizabeth Cairns, a reporter at Endpoints News, pointed out that while pills would likely increase adherence, oral drugs are often dosed at higher levels than injections, which means they often come with more side effects
Adverse events of GLP-1 receptor agonists for weight loss: Twitter and a national pharmacovigilance database
Gastrointestinal Distress Digestive issues like nausea, vomiting, or diarrhoea have been reported in rare cases after glutathione injections